Propel Bio Management »

Mirum Pharmaceuticals shares owned by Propel Bio Management

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1M 70k 29.52

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
BVF
Eventide Asset Management
Vanguard Group
Henderson Group
Cadian Capital Management
Citadel Advisors
T. Rowe Price Associates
Avidity Partners Management
Tang Capital Management
Franklin Resources
First Turn Management
William Blair Investment Management
Perceptive Advisors
Boone Capital Management

View all funds holding Mirum Pharmaceuticals